Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

With guest editor Jennifer Doudna, CRISPR pioneer

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

Concerns over the spread of the novel coronavirus leads to decision

Spring lineup of conferences and events frequented by chemists is slashed

Complaint alleges trade secret theft, patent infringement on separator films

The technique, called MicroMapping, identifies potential protein interactions on and between cells

#ACSPhilly is one of many scientific conferences postponed or canceled because of concerns over COVID-19

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery

Models predict an ‘alloy' of H and O is a metallic fluid in the ice giants' interior

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data

Reactors arranged around a central switching station gives chemists more options for making molecules remotely

Posters and presentations can be uploaded to SciMeetings starting on March 19

New material captures greater share of “forever chemicals” from water than other methods

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

New approach captures greater share of ‘forever chemicals' from water than other methods

Polyaniline coating changes the firing frequency of targeted neurons

Large, disordered pores allow the gel to capture soil without damaging pigments

Chemical educator and <i>Compound Interest</i> blogger Andy Brunning digs into how plant fertilizers make use of the periodic table.

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Nearly perfect, long-lasting crystalline catalyst turns CO₂ into valuable products

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Chemically distinct regions of alloys can help create strong yet flexible nanostructured metals

Activists say broad lack of enforcement threatens safety

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

These biomolecules could hold clues to why the virus is so infectious and to how to stop it

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Long-sought phosphatetrahedrane could lead to new organophosphorus compounds

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints

Activists say broad lack of enforcement threatens safety

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2

Inspector general finds agency hasn't reached out to those living near 9 chemical plants

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology's make-or-break moment.

Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives